Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin R Robertson

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The Lancet. HIV|June 19, 2019
Markers of persistent HIV replication in the CNSAlyssa C Vecchio, Kevin R Robertson
Current HIV/AIDS Reports|August 13, 2011
Neurocognitive impact of antiretroviral treatment: thinking long-termMegan E McPhail, Kevin R Robertson
The AIDS Reader|June 21, 2005
Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAARTThomas D Parsons, Kevin R Robertson
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Assessment of neuroAIDS in the international settingKevin R Robertson, Colin D Hall
AIDS (London, England)|November 27, 2014
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?Jonathan Underwood, Kevin R Robertson, Alan Winston
Current HIV/AIDS Reports|April 29, 2010
HIV, antiretroviral therapies, and the brainKevin J Liner, Michelle J Ro, Kevin R Robertson
Journal of Neurovirology|September 13, 2007
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological diseaseKevin J Liner, Colin D Hall, Kevin R Robertson
Current HIV/AIDS Reports|May 31, 2008
Effects of antiretroviral therapy on cognitive impairmentKevin J Liner, Colin D Hall, Kevin R Robertson
Health and Quality of Life Outcomes|March 1, 2006
Better quality of life with neuropsychological improvement on HAARTThomas D Parsons, Alyssa J Braaten, Colin D Hall, et al.
Journal of Neurovirology|July 23, 2005
Cerebrospinal fluid from human immunodeficiency virus--infected individuals facilitates neurotoxicity by suppressing intracellular calcium recoveryRick B Meeker, Jeramiah C Boles, Kevin R Robertson, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The Lancet. HIV|June 19, 2019
Markers of persistent HIV replication in the CNSAlyssa C Vecchio, Kevin R Robertson
Current HIV/AIDS Reports|August 13, 2011
Neurocognitive impact of antiretroviral treatment: thinking long-termMegan E McPhail, Kevin R Robertson
The AIDS Reader|June 21, 2005
Editorial comment: treatment of HIV-associated cognitive impairment--beyond HAARTThomas D Parsons, Kevin R Robertson
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Assessment of neuroAIDS in the international settingKevin R Robertson, Colin D Hall
AIDS (London, England)|November 27, 2014
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?Jonathan Underwood, Kevin R Robertson, Alan Winston
Current HIV/AIDS Reports|April 29, 2010
HIV, antiretroviral therapies, and the brainKevin J Liner, Michelle J Ro, Kevin R Robertson
Journal of Neurovirology|September 13, 2007
Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological diseaseKevin J Liner, Colin D Hall, Kevin R Robertson
Current HIV/AIDS Reports|May 31, 2008
Effects of antiretroviral therapy on cognitive impairmentKevin J Liner, Colin D Hall, Kevin R Robertson
Health and Quality of Life Outcomes|March 1, 2006
Better quality of life with neuropsychological improvement on HAARTThomas D Parsons, Alyssa J Braaten, Colin D Hall, et al.
Journal of Neurovirology|July 23, 2005
Cerebrospinal fluid from human immunodeficiency virus--infected individuals facilitates neurotoxicity by suppressing intracellular calcium recoveryRick B Meeker, Jeramiah C Boles, Kevin R Robertson, et al.
Pageof 7